Conference Coverage

Physician, know thy patient before recommending treatment


 

AT THE NCCN ANNUAL CONFERENCE

References

Discussion informs choices

The investigators looked at how prediagnosis education materials and discussions with urologists shaped patient decisions about treatment choice. Patients were called before their appointments to ensure that they had read the booklet, and then just before the appointment were asked which way they were leaning if the diagnosis turned out to be positive.

The investigators found that of 44 patients who expressed a preference for active surveillance before the appointment, 55% actually went on to receive active treatment. Among 119 patients with no expressed preference for surveillance or active therapy, 46% went on to treatment, and of 118 expressing previsit preference only for active surveillance, 54% went on to receive it.

“The leaning that they had before seeing the doctor had no influence on what treatment they got,” Dr. Ubel said. Instead, physicians’ recommendations had a strong influence on treatment choice. Recommendations are an essential part of the discussion, “but I don’t think we often do them well,” he said.

Ask patients to think out loud about what they have read or have been told, and ask them to repeat in their own words what they heard the doctor say, Dr. Ubel suggested. It’s incumbent on the physician to try to understand the patient’s preferences, and say something like, “I’m the expert on medical facts, but you’re the expert on you,” or “What sounds good and bad to you about that treatment alternative?”

Finally, physicians need to make recommendations based on patient preferences, he said.

For example, in one recorded encounter, the physician asked the patient, “Are you the kind of person where the idea of just watching your PSA is that unsettling to you?” When the patient replied “Yeah, I think I would be,” the physician was able to make an informed recommendation, saying “then I don’t think you’d be a good candidate for surveillance.”

“This doctor did not just make a recommendation; he tried to find out something about the patient first, and that’s critical to giving good advice,” Dr. Ubel said.

Pages

Recommended Reading

Testicular cancer patients who fare well early on have smooth sailing thereafter
MDedge Internal Medicine
Hypofractionated radiation emerges as new standard of care for prostate cancer
MDedge Internal Medicine
Enzalutamide cuts disease progression, death in CRPC
MDedge Internal Medicine
ADT resistance signature predicts failure of hormone therapy for prostate cancer
MDedge Internal Medicine
Statins don’t appear to compromise effectiveness of abiraterone
MDedge Internal Medicine
Diet, lifestyle factors add up in reducing risk of prostate cancer death
MDedge Internal Medicine
Radiotherapy for prostate cancer linked to higher risk of secondary malignancies
MDedge Internal Medicine
Trial supports combined androgen suppression, radiotherapy for prostate cancer
MDedge Internal Medicine
Large cohort study confirms link between pioglitazone, bladder cancer
MDedge Internal Medicine
PSA screens could be cost effective if low-risk cases went untreated
MDedge Internal Medicine